Literature DB >> 33392995

Intestinal Electrical Stimulation Alters Hypothalamic Expression of Oxytocin and Orexin and Ameliorates Diet-Induced Obesity in Rats.

Shiying Li1,2, Yeram Kim1, Jiande D Z Chen2, Mohammad F Madhoun3,4.   

Abstract

BACKGROUND: Intestinal electrical stimulation (IES) has been proposed as a potential treatment for obesity. The aim of this study was to explore the central mechanism underlying the reduction of food intake and body weight by IES by studying the expression of anorexigenic- and orexigenic-peptide-containing neurons in the hypothalamus.
MATERIALS AND METHODS: Diet-induced obese (DIO) rats were divided into three groups to receive sham, IES, and pair-feeding for 4 weeks. Food intake was measured automatically and presented as daily and body weight measured weekly. The expressions of oxytocin, an anorexigenic neuropeptide, in the paraventricular nucleus of the hypothalamus (PVN) and the supraoptic nuclei of the hypothalamus (SON) and orexin-A, an orexigenic neuropeptide, in the lateral hypothalamic area (LHA) were studied using immunohistochemistry.
RESULTS: Compared with sham, IES reduced daily food intake by 28.3% at week 1, 35.6% at week 2, 15.6% at week 3, and 27.1% at week 4. Consistently, IES reduced body weight by 6.3%, compared with a weight gain of 7.2% in sham, and a slight weight loss of 0.5% in pair-feeding. Compared with sham, IES increased the expression of oxytocin-immunoreactive neurons in PVN and SON. Compared with sham, IES decreased the expression of orexin-immunoreactive neurons in LHA. Rats with pair-feeding also showed a relative decease in weight without any changes in the central hormones.
CONCLUSION: IES reduces food intake and body weight and improves glucose tolerance and insulin sensitivity in DIO rats. Its central mechanisms involve enhancement of anorexigenic peptides and suppression of orexigenic peptides in the hypothalamus.

Entities:  

Keywords:  Immunohistochemistry; Intestinal electrical stimulation; Obesity treatment; Orexin; Oxytocin

Mesh:

Substances:

Year:  2021        PMID: 33392995     DOI: 10.1007/s11695-020-05177-w

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  37 in total

1.  Implantable gastric stimulation (IGS) as therapy for human morbid obesity: report from the 2001 IFSO symposium in Crete.

Authors:  Robert J Greenstein; Mitiku Belachew
Journal:  Obes Surg       Date:  2002-04       Impact factor: 4.129

2.  Intestinal electric stimulation decreases fat absorption in rats: therapeutic potential for obesity.

Authors:  Ying Sun; Jiande Chen
Journal:  Obes Res       Date:  2004-08

Review 3.  Surgical treatment of morbid obesity.

Authors:  Peter F Crookes
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

4.  Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).

Authors:  Maurizio De Luca; Luigi Angrisani; Jacques Himpens; Luca Busetto; Nicola Scopinaro; Rudolf Weiner; Alberto Sartori; Christine Stier; Muffazal Lakdawala; Aparna G Bhasker; Henry Buchwald; John Dixon; Sonja Chiappetta; Hans-Christian Kolberg; Gema Frühbeck; David B Sarwer; Michel Suter; Emanuele Soricelli; Mattias Blüher; Ramon Vilallonga; Arya Sharma; Scott Shikora
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

5.  Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity.

Authors:  Zachary J Ward; Sara N Bleich; Angie L Cradock; Jessica L Barrett; Catherine M Giles; Chasmine Flax; Michael W Long; Steven L Gortmaker
Journal:  N Engl J Med       Date:  2019-12-19       Impact factor: 91.245

Review 6.  Surgical treatment of morbid obesity.

Authors:  P M Sagar
Journal:  Br J Surg       Date:  1995-06       Impact factor: 6.939

7.  Pulse Width-Dependent Effects of Intestinal Electrical Stimulation for Obesity: Role of Gastrointestinal Motility and Hormones.

Authors:  Shiying Li; Jiande D Z Chen
Journal:  Obes Surg       Date:  2017-01       Impact factor: 4.129

8.  Gastric pacing as therapy for morbid obesity: preliminary results.

Authors:  Valerio Cigaina
Journal:  Obes Surg       Date:  2002-04       Impact factor: 4.129

9.  Treatment of morbid obesity with the Transcend Implantable Gastric Stimulator (IGS): a prospective survey.

Authors:  Franco Favretti; Maurizio De Luca; Gianni Segato; Luca Busetto; Andrea Ceoloni; Alessandro Magon; Giuliano Enzi
Journal:  Obes Surg       Date:  2004-05       Impact factor: 4.129

10.  abiliti Closed-Loop Gastric Electrical Stimulation System for Treatment of Obesity: Clinical Results with a 27-Month Follow-Up.

Authors:  T Horbach; A Thalheimer; F Seyfried; F Eschenbacher; P Schuhmann; G Meyer
Journal:  Obes Surg       Date:  2015-10       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.